Search clinical trials for: Angiotensin II type 1 receptor antagonists

Total 3842 results

Takeda

Completed

Efficacy of Candesartan on Symptomatic Heart Failure in Treating Diabetic and Hypertensive Patients.

Heart Failure

Germany
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Study of Inherited Changes of Receptors Located on Blood Vessels

Cardiovascular Disease

United States
Fifth Affiliated Hospital, Sun Yat-Sen University
Third Affiliated Hospital, Sun Yat-Sen University

Not yet recruiting

Nighttime Valsartan in Hemodialysis Hypertension (NVHH)

Hypertension;Nephropathy
Emory University
National Institute on Aging (NIA)

Completed

Candesartan's Effects on Alzheimer's Disease And Related Biomarkers (CEDAR)

Mild Cognitive Impairment

United States
Children's Hospital Medical Center, Cincinnati

Completed

Losartan to Reverse Sickle Nephropathy

Sickle Cell Anemia | Nephropathy

United States
Takeda

Completed

International Multicenter, Observational, Non-Interventional Prospective Study of Azilsartan Medoxomil in Participants With Arterial Hypertension Who Are Overweight or Obese in the Russian Federation and The Republic of Kazakhstan

Hypertension

Russian Federation, Kazakhstan
Takeda

Completed

Azilsartan Medoxomil in the Treatment of Essential Hypertension and Type 2 Diabetes in Asia

Type 2 Diabetes Mellitus | Essential Hypertension

Taiwan, Thailand, China
Wake Forest University Health Sciences
Johns Hopkins University

Terminated

Angiotensin Receptors and Age Related Mitochondrial Decline in HIV Patients (RAS-HIV)

HIV | Sarcopenia | Aging | Angiotensin Receptor Antagonists

United States
Mitsubishi Tanabe Pharma Corporation

Completed

Drug-Drug Interaction Study to Evaluate the Effect of Colestilan on the Pharmacokinetics of Single Doses of Candesartan Cilexetil in Healthy Subjects

Chronic Kidney Disease | Hyperphosphatemia

United Kingdom
Boehringer Ingelheim

Completed

Study to Evaluate Efficacy of Micardis® (Telmisartan) and Valsartan in Patients With Mild-to-moderate Hypertension After Missing One Dose Using Ambulatory Blood Pressure Monitoring

Hypertension
Boehringer Ingelheim

Completed

Post-Marketing Surveillance Study of Micardis® Plus in Patients With Hypertension

Hypertension
Boryung Pharmaceutical Co., Ltd
Asan Medical Center; Chonnam National University Hospital; Seoul National University... and other collaborators

Completed

A Valsartan 80 Mg-Referenced, Therapeutic Exploratory Clinical Study to Evaluate the Antihypertensive Efficacy of Fimasartan 30 mg During 24 Hours in Patients With Mild to Moderate Essential Hypertension

Essential Hypertension

Korea, Republic of
AstraZeneca

Completed

Efficacy Observational Study of Candesartan Cilexetil on Hypertensive Patients

Primary Hypertension

Romania
Takeda

Recruiting

A Study of Azilsartan in Children From 6 to Less Than 16 Years Old With High Blood Pressure

Hypertension

Japan
Massachusetts General Hospital
National Cancer Institute (NCI)

Active, not recruiting

Hearing Outcomes Using Fractionated Proton Radiation Therapy for Vestibular Schwannoma

Vestibular Schwannoma | Acoustic Neuroma

United States
Josep M Cruzado

Recruiting

Renin Angiotensin System Blockade in Renal Transplant Patients With Presence of PECs in Urine

Chronic Kidney Allograft Nephropathy

Spain
Fifth Affiliated Hospital, Sun Yat-Sen University
Third Affiliated Hospital, Sun Yat-Sen University

Not yet recruiting

Nighttime Losartan in Continous Ambulatory Peritoneal Dialysis (NVCAPD)

Hypertension,Nephropathy
University of Alabama at Birmingham
National Heart, Lung, and Blood Institute (NHLBI)

Terminated

Preventing Sickle Cell Kidney Disease

Hypertension | Proteinuria | Sickle Cell Disease | Anemia, Sickle Cell | Kidney Disease

United States
Boryung Pharmaceutical Co., Ltd
Asan Medical Center; Ulsan University Hospital; Korea University Anam Hospital; Dong-A University and other collaborators

Completed

A Multicenter, Phase 3 Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan(BR-A-657∙K) 30mg Compared to Placebo in Patients With Mild to Moderate Essential Hypertension (fimasartan)

Hypertension

Korea, Republic of
Korea University Anam Hospital

Completed

Comparison of Effects of Telmisartan and Valsartan on Neointima Volume in Diabetes

Coronary Artery Disease | Hypertension | Diabetes

Korea, Republic of
Takeda

Terminated

Efficacy and Safety of Azilsartan Medoxomil Used in Combination With Metformin in Participants With Hypertension and Diabetes

Hypertension | Diabetes

United States
Boehringer Ingelheim

Completed

Evolution of Pulse Pressure Following Initiation of Antihypertensive Therapy in Patients With Essential Arterial Hypertension

Hypertension
Boehringer Ingelheim

Completed

Study to Evaluate the Trough and Peak Effect of Once Daily Telmisartan 80 mg/Hydrochlorothiazide 12.5 mg (Micardis Plus) by Ambulatory Blood Pressure Monitoring (ABPM) in Patients With Mild to Moderate Essential Hypertension

Hypertension

China
Nara Medical University

Completed

New Angiotensin II Receptor Blocker Azilsartan Study for Stronger Blood Pressure Lowering (NARA)

Hypertension

Japan
Ligand Pharmaceuticals

Completed

A Study To Evaluate The Dose-Related Efficacy and Safety of PS433540 in Subjects With Hypertension

Hypertension

United States
Bayer

Completed

The Real-Life Efficacy and Safety of Telmisartan in Patients With Arterial Hypertension (METABOLIC)

Hypertension

Poland, Slovakia, Croatia, Slovenia
Shanghai Jiao Tong University School of Medicine

Completed

Adiponectin in Obese Women With T2DN and Effects by RAS Blocker

Diabetic Nephropathy | Type 2 Diabetes | Obese | Glucose Metabolism | Angiotensin II Type 1 Receptor Blockers
The University of Hong Kong

Recruiting

Exercise-induced Erythropoiesis: the Mechanistic of Angiotensin II

Exercise Physiology

Hong Kong
University Hospital, Limoges

Withdrawn

Efficacy of Angiotensin Receptor Blocker Following aortIc Valve Intervention for Aortic STenOsis: a Randomized mulTi-cEntric Double-blind Phase II Study (ARISTOTE)

Aortic Valve Stenosis | Transcatheter Aortic Valve Replacement | Hypertrophy, Left Ventricular | Angiotensin Receptor Antagonists | Heart Valve Prosthesis Implantation | Valsartan

France
JHSPH Center for Clinical Trials
University of Pittsburgh

Completed

Losartan Effects on Emphysema Progression (LEEP)

Emphysema

United States
University Hospital, Limoges

Terminated

Candesartan in Peripheral Neuropathy (NEUPERSART)

Peripheral Neuropathy

France
The Hospital for Sick Children

Suspended

Pilot Trial: the Safety and Feasibility of Losartan for Pulmonary Vein Stenosis

Children | Pulmonary Vein Stenosis

Canada
Assistance Publique - Hôpitaux de Paris

Terminated

Study of the Efficacy of Losartan on Aortic Dilatation in Patients With Marfan Syndrome (MARFANSARTAN)

Marfan Syndrome

France
Boehringer Ingelheim

Completed

Micardis® in Patients With Essential Hypertension

Hypertension
Boehringer Ingelheim

Completed

MICARDIS® and Valsartan in Patients With Mild-to-Moderate Hypertension Using Ambulatory Blood Pressure Monitoring

Hypertension
IlDong Pharmaceutical Co Ltd

Unknown

A Bioequivalence Study Comparing Cilnidipine/Valsartan Combination Tablet With Coadministration of Cilnidipine and Valsartan

Healthy Volunteers

Korea, Republic of
Novartis

Completed

Clinical Trial To Evaluate The Effect Of Valsartan On Insulin Sensitivity In Subjects With Impaired Glucose Tolerance

Hypertension | Impaired Glucose Tolerance
Hallym University Medical Center

Unknown

Valsartan Efficacy on Modest Blood Pressure Reduction in Acute Ischemic Stroke (VENTURE)

Acute Ischemic Stroke

Korea, Republic of
Sanofi
Bristol-Myers Squibb

Completed

I PREVENT - Irbesartan In Hypertensive Diabetic Patients

Hypertension

Egypt
Sanofi
Bristol-Myers Squibb

Completed

I SAVE - Irbesartan in Mild to Moderate Hypertensive Patients

Hypertension

Egypt
Astellas Pharma Inc

Completed

A Study to Assess the Effect of ASP1585 on Pharmacokinetics of Valsartan in Healthy Volunteers

Healthy | Pharmacokinetics of Valsartan

Japan
University of Helsinki
AstraZeneca

Unknown

The Potential of Candesartan to Retard the Progression of Aortic Stenosis (ROCK-AS)

Aortic Valve Stenosis

Finland
Hospital Clinic of Barcelona

Completed

Effects of Losartan on Hepatic Fibrogenesis in Chronic Hepatitis C

Chronic Hepatitis C | Liver Fibrosis
German Heart Institute
Charite University, Berlin, Germany; Merck Sharp & Dohme LLC

Unknown

PPARgamma Activation by Losartan in Hypertensive Patients: The Importance of Losartan-Metabolites

Hypertension

Germany
Kitasato University
Yokohama City University Medical Center; St. Marianna University School of... and other collaborators

Unknown

Intensive Medical Treatment for Nephropathy Caused by Type 2 Diabetes With Hypertension

Hypertension | Type 2 Diabetes Mellitus

Japan
University of Kansas Medical Center

Completed

Study of Open Label Losartan in COVID-19

COVID-19

United States
Seoul National University Hospital
Ministry of Food and Drug Safety, Korea

Completed

Efficacy and Safety of Losartan in Children With Ig A Nephropathy

Glomerulonephritis, IGA

Korea, Republic of
Johns Hopkins University
National Institutes of Health (NIH); National Institute on Aging (NIA)

Completed

A Study of Muscle Strength Maintenance in Older Adults

Sarcopenia

United States
Academisch Medisch Centrum - Universiteit van Amsterdam...
The Interuniversity Cardiology Institute of the Netherlands

Unknown

Right Ventricular Dysfunction in Tetralogy of Fallot: Inhibition of the Renin-angiotensin-aldosterone System (Redefine)

Heart Defects, Congenital | Tetralogy of Fallot | Ventricular Dysfunction, Right

Netherlands
Melbourne Health

Completed

Attenuation of Cardiac Effects of Arteriovenous Fistula Creation With Losartan

Renal Failure | Left Ventricular Hypertrophy

Australia

Search clinical trials for: Angiotensin II type 1 receptor antagonists

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Vietnam

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations